Utah Medical Products (UTMD) Operating Leases (2019 - 2025)
Historic Operating Leases for Utah Medical Products (UTMD) over the last 7 years, with Q2 2025 value amounting to $256000.0.
- Utah Medical Products' Operating Leases fell 690.91% to $256000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $256000.0, marking a year-over-year decrease of 690.91%. This contributed to the annual value of $282000.0 for FY2024, which is 440.68% down from last year.
- Latest data reveals that Utah Medical Products reported Operating Leases of $256000.0 as of Q2 2025, which was down 690.91% from $282000.0 recorded in Q4 2024.
- Over the past 5 years, Utah Medical Products' Operating Leases peaked at $396000.0 during Q4 2021, and registered a low of $256000.0 during Q2 2025.
- Its 5-year average for Operating Leases is $322058.8, with a median of $322000.0 in 2021.
- Within the past 5 years, the most significant YoY rise in Utah Medical Products' Operating Leases was 1820.9% (2021), while the steepest drop was 1856.44% (2021).
- Utah Medical Products' Operating Leases (Quarter) stood at $396000.0 in 2021, then dropped by 13.89% to $341000.0 in 2022, then fell by 13.49% to $295000.0 in 2023, then decreased by 4.41% to $282000.0 in 2024, then decreased by 9.22% to $256000.0 in 2025.
- Its Operating Leases stands at $256000.0 for Q2 2025, versus $282000.0 for Q4 2024 and $299000.0 for Q3 2024.